In addition to reviewing the structure and localization of TYROBP, the authors discuss their recent progress using mouse models of either cerebral amyloidosis or tauopathy that were engineered to be TYROBP-deficient or TYROBP-overexpressing.
[Molecular Neurodegeneration]